Evonik Industries AG's revenue for the
three
months ended in Mar. 2026 was CHF3,119 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2026 was CHF12,745 Mil.
Evonik Industries AG's Revenue per Share for the
three
months ended in Mar. 2026 was CHF6.74.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was CHF27.54.
Warning Sign:
Evonik Industries AG revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of Evonik Industries AG was -7.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -8.70% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 1.60% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 1.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Evonik Industries AG's highest 3-Year average Revenue per Share Growth Rate was 12.10% per year. The lowest was -9.40% per year. And the median was 0.10% per year.
Evonik Industries AG (XSWX:EVK) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, Evonik Industries AG's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Evonik Industries AG Revenue vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Evonik Industries AG's Revenue distribution charts can be found below:
* The bar in red indicates where Evonik Industries AG's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF12,745 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Evonik Industries AG (XSWX:EVK) has a Revenue of CHF12,745 Mil as of Mar. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Evonik Industries AG and its competitors.
Is Evonik Industries AG's Revenue too high?
Evonik Industries AG's current Revenue is CHF12,745 Mil. Overall, Evonik Industries AG has a GF Score™ of 16/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Evonik Industries AG's Revenue compare to LIN and SHW?
Evonik Industries AG's Revenue of CHF12,745 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Chemicals company?
A good Revenue depends on the Chemicals industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Evonik Industries AG and its competitors. Evonik Industries AG's current Revenue is CHF12,745 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evonik Industries AG stock overvalued right now?
Based on GuruFocus' analysis, Evonik Industries AG (XSWX:EVK) is currently considered Fairly Valued. The stock's GF Value™ is CHF14.43, compared to a current price of CHF14.54 — trading 0.8% above its estimated fair value. The current Revenue is CHF12,745 Mil. Evonik Industries AG's overall GF Score™ is 16/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Evonik Industries AG (XSWX:EVK), the current Revenue is CHF12,745 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Evonik Industries AG (XSWX:EVK) Overvalued in 2026?
Based on GuruFocus' analysis, Evonik Industries AG stock appears to be overvalued.
The current stock price of CHF14.54 is trading 0.8% above its estimated GF Value™ of CHF14.43.
GuruFocus considers Evonik Industries AG to be Fairly Valued.
Key valuation signals for XSWX:EVK:
Revenue: CHF12,745 Mil
GF Value™: CHF14.43 vs. price of CHF14.54 (0.8% above fair value)
No single metric tells the full story. See the XSWX:EVK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Evonik Industries AG is a chemicals company that develops and manufactures specialty chemicals and solutions for a wide range of industries. Its products include high-performance polymers, hydrogen peroxide, silicas, additives for coatings and adhesives, and amino acids for animal nutrition. It operates through three segments: Advanced Technologies, which focuses on technology-driven businesses such as high-performance polymers, silicas, and hydrogen peroxide; Custom Solutions, which develops additives, catalysts, and ingredients for personal care and pharmaceutical applications; and Infrastructure, which provides site-related infrastructure services and includes the Oxeno C4 chemicals business. It generates sales across Europe, Middle East & Africa, the Americas, and Asia-Pacific.
16GF Score
Get the complete analysis for XSWX:EVK
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:EVK has been successfully added to your 
